Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology by unknown
Lei et al. BMC Genomics 2013, 14:804
http://www.biomedcentral.com/1471-2164/14/804RESEARCH ARTICLE Open AccessIdentification and characterization of EBV
genomes in spontaneously immortalized human
peripheral blood B lymphocytes by NGS
technology
Haiyan Lei, Tianwei Li, Guo-Chiuan Hung, Bingjie Li, Shien Tsai and Shyh-Ching Lo*Abstract
Background: We conducted genomic sequencing to identify Epstein Barr Virus (EBV) genomes in 2 human
peripheral blood B lymphocytes that underwent spontaneous immortalization promoted by mycoplasma infections
in culture, using the high-throughput sequencing (HTS) Illumina MiSeq platform. The purpose of this study was to
examine if rapid detection and characterization of a viral agent could be effectively achieved by HTS using a
platform that has become readily available in general biology laboratories.
Results: Raw read sequences, averaging 175 bps in length, were mapped with DNA databases of human,
bacteria, fungi and virus genomes using the CLC Genomics Workbench bioinformatics tool. Overall 37,757 out
of 49,520,834 total reads in one lymphocyte line (# K4413-Mi) and 28,178 out of 45,335,960 reads in the other
lymphocyte line (# K4123-Mi) were identified as EBV sequences. The two EBV genomes with estimated 35.22-fold and
31.06-fold sequence coverage respectively, designated K4413-Mi EBV and K4123-Mi EBV (GenBank accession number
KC440852 and KC440851 respectively), are characteristic of type-1 EBV.
Conclusions: Sequence comparison and phylogenetic analysis among K4413-Mi EBV, K4123-Mi EBV and the EBV
genomes previously reported to GenBank as well as the NA12878 EBV genome assembled from database of the
1000 Genome Project showed that these 2 EBVs are most closely related to B95-8, an EBV previously isolated from
a patient with infectious mononucleosis and WT-EBV. They are less similar to EBVs associated with nasopharyngeal
carcinoma (NPC) from Hong Kong and China as well as the Akata strain of a case of Burkitt’s lymphoma from Japan.
They are most different from type 2 EBV found in Western African Burkitt’s lymphoma.
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Epstein-Barr virus (EBV) is a ubiquitous gamma-herpesvirus
highly prevalent in all human populations. The virus is asso-
ciated with both non-malignant diseases and a number of
human cancers. After the first discovery of EBV particles in
cultured lymphoma cells from patients with Burkitt’s lymph-
oma (BL) [1,2], EBV and its encoded molecules were also
detected in other disease processes and malignancies
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reproduction in any medium, provided the or[3], infectious mononucleosis [4], Hodgkin’s disease [5,6],
and gastric carcinoma [7,8] etc.
Eight EBV whole-genome sequences have been reported
from previous studies. B95-8 (GenBank accession number
V01555.2), derived from a North American case of infec-
tious mononucleosis [9], was the first completely sequenced
EBV genome. A more complete 171 kb wild-type EBV
reference genome, WT-EBV, (GenBank accession num-
ber NC_007605.1/AJ507799.2) was later constructed using
B95-8 as a backbone while an 12 kb missing fragment in
the EBV genome was provided by the EBV sequence found
in Raji cells [10,11]. AG876 (DQ279927.1) from a Western
African case of Burkitt’s lymphoma is the only completeThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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GD2 (HQ020558.1) and HKNPC1 (JQ009376.1) are
all EBV genomes derived from NPC patients or NPC
tumours. Specifically, GD1 was isolated from the saliva
of an NPC patient, while GD2 and HKNPC1 were iso-
lated from an NPC tumour or tumour biopsy. GD1 was
sequenced using the conventional shotgun sequencing.
GD2 and HKNPC1 were very recently sequenced using
the next generation sequencing (NGS) Illumina platform
[13-15]. Moreover, 2 EBV genomes, Akata (KC207813)
and Mutu (KC207814), were reported recently from cases
of Burkitt’s lymphomas from Japan and Kenya, respect-
ively, by NGS technology [16].
Our laboratory has recently established a new high
throughput sequencing (HTS) capability using the MiSeq
platform. Currently, we are evaluating various workflows
using different programs/tools for the effective detection
of a target viral genome as well as novel viral genes in
computational analysis of massive amounts of sequencing
data generated by NGS technology. Our objective is to
effectively detect and characterize infectious viruses in
human host cells or tissues intended as therapeutic bio-
logics by using the new technology. For this purpose, we
conducted an experimental genomic sequencing study
of 2 human B cell lines that underwent spontaneous
immortalization promoted by infection of the cell culture
with mycoplasma [17]. These 2 immortalized human B
lymphocyte cell lines were previously shown to be mono-
clonal in nature and positive for the EBV LMP1 antigen
[17]. Using available computational tools, we identified
and extracted EBV sequences from genomic sequencing
data of the 2 B-lymphocyte cell lines, assembled them into
single genomes and compared them with the sequences of
all the EBV genomes previously reported to the GenBank.
In addition, we identified and extracted EBV sequences
from the 1000 human genomes project sequences which
had been deposited in NCBI for comparison. The project
has been studying human genomic DNA of human per-
ipheral blood B lymphocytes immortalized by EBV in-
fections in culture. The present study provided a rapid
genomic comparison and characterization of EBV strains
associated with different human diseases along with their
pathogenesis and geographical distributions.
Results
Taxonomic classification of sequences obtained from
MiSeq
DNAs were isolated from the cultures of 2 previously
established, spontaneously immortalized human B lympho-
cyte cell lines (K4413-Mi and K4123-Mi) for genomic
sequencing. A total of 49,520,834 sequencing reads of
168-base paired-end reads were generated by the MiSeq
sequencer resulting in 8.3 Gb of sequence data from the
K4413-Mi cell line. Similarly, a total of 45,335,960 readsof 198-base paired-end reads resulting in 8.9 Gb of se-
quence data were collected from the K4123-Mi cell line.
Those short reads that passed quality control filtering
were first aligned to the database of human reference
genome sequences (hg19, GRCh37; http://hgdownload.
cse.ucsc.edu/goldenPath/hg19/bigZips/). After removing
the sequencing reads that aligned with human reference
genome database, the remaining reads were aligned
against the bacterial, fungal, and viral nucleotide data-
bases sequentially (ftp://ftp.ncbi.nlm.nih.gov/genomes/
Bacteria/, 04/27/2013 version; ftp://ftp.ncbi.nlm.nih.gov/
genomes/Fungi/, 03/25/2013 version; ftp://ftp.ncbi.nlm.
nih.gov/genomes/Viruses/, 05/22/2013 version) to deter-
mine the sequence composition using CLC Genomic
Workbench (http://www.clcbio.com/, version 6.0.2). Of
the 49,520,834 sequencing reads from K4413-Mi cell
line, 97.2% (48,132,751 reads), 0.011% (5,753 reads),
0.025% (12,572 reads), and 0.075% (36,904 reads) were
classified as human, bacteria, fungi, and virus related
sequences, respectively (Figure 1A). Of the 45,335,960
original reads from K4123-Mi cell line, 98.6% (44,712,404
reads), 0.017% (7,759 reads), 0.019% (8,714 reads) and
0.059% (26,528 reads) were classified as human, bacteria,
fungi, and virus related sequences, respectively (Figure 1C).
Of the virus-related reads identified in both cell lines,
97.6% of 36,904 reads in the K4413-Mi cell line and
98.1% of 26,528 reads in the K4123-Mi cell line were
classified as EBV-specific sequences (Figure 1B, 1D). In
the K4413-Mi cell line virus-related reads, there were
281 short reads classified as sequences related to Entero-
bacteria phage phiX174. There were 593 and 548 short
reads classified as “other Herpesvirus” in K4413-Mi
and K4123-Mi cell line virus-related reads, respectively
(Figures 1B, D).
Assembly of EBV genomes from sequences mapping
with WT-EBV
In order to assemble the K4413-Mi and K4123-Mi EBV
genomes, we mapped the total sequencing reads of
K4413-Mi and K4123-Mi to the reported EBV reference
genome (WT-EBV, NC_007605) separately using the CLC
Genomics Workbench. The mapped reads were consid-
ered to represent EBV-related sequences. Overall 37,757
out of 49,520,834 total reads in one lymphocyte line
(K4413-Mi Line) and 28,178 out of 45,335,960 total reads
in the second lymphocyte line (K4123-Mi Line) were
identified as EBV-related sequences. The EBV-related
sequences identified in K4413-Mi cell line covered 99.99%
of the entire reference WT-EBV genome. The average
coverage was 35.22-fold. There were 10 gaps in the
K4413-Mi EBV genome assembled, with gap lengths
varying from 1 bp to 105 bp. The total gap length was
352 bp. For the K4123-Mi EBV genome assembly, the
EBV-related sequences identified covered 99% of the
Figure 1 Summary of the distribution of K4413-Mi and K4123-Mi sequence reads mapping to human, bacterial, fungal, and viral databases.
The pie charts were generated based on the results of a homology search for all of the short reads. (A) K4413-Mi all reads distribution. (B) K4413-Mi
virus reads distribution. (C) K4123-Mi all reads distribution. (D) K4123-Mi virus reads distribution.
Lei et al. BMC Genomics 2013, 14:804 Page 3 of 9
http://www.biomedcentral.com/1471-2164/14/804WT-EBV reference genome. The average coverage was
31.06-fold. There were 18 gaps in the K4123-Mi EBV
genome assembled, and the gap length varied from 1 bp
to 177 bp. The total gap length was 993 bp. Finally,
the complete genome of K4413-Mi EBV was 171,843 bp
(with 352 “N”). The K4123-Mi EBV genome was 171,793 bp
(with 993 “N”). Both genomes have a GC-content of 59.5%.
Both genomes were also annotated using the informa-
tion derived from the reference genome of WT-EBV
(NC_007605) sequence, and submitted to GenBank
(GenBank accession number KC440852 and KC440851).
Identification and extraction of EBV sequences from
NA12878 data
To evaluate if the bioinformatics tool used in the study
could be equally effective in identifying and characteriz-
ing viral genome sequences from much more massive
human genome sequencing data generated by NGS tech-
nology and to compare genome sequences of EBV iden-
tified in our “spontaneously” immortalized B cells with
those in B cells transformed by acute EBV infection inculture, we downloaded sequencing raw data from NCBI
of 1000 human genomes project. In the human1000 ge-
nomes project (http://www.1000genomes.org/), human
genomic DNA was isolated from human B cells immor-
talized by EBV infection in culture [18] and deeply se-
quenced. The human genomic sequences obtained by
this project have been deposited in NCBI. In this study
we identified and extracted the EBV sequences from
NA12878 human genomic sequences deposited in NCBI
for comparison with EBVs in our B-cell lines. We down-
loaded 846,783,709 Illumina 36 bp short reads from
ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/data/NA12878/
sequence_read/ and used CLC Genomics Workbench soft-
ware to map these reads with the WT-EBV reference
genome (NC_007605). In the total reads downloaded,
2,219,104 (0.26%) short reads mapped with the WT-EBV
and covered 100% of the reference genome. We assembled
the NA12878 EBV genome sequence from the raw reads
mapping to the WT-EBV. We obtained a single contig
with 171,852 bp consensus sequence from the assembly.
We named the consensus sequence of the EBV genome
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human lymphocyte induced by infection of B95-8 EBV
carried 102 copies of EBV genomes.
Since the large majority of the human peripheral blood
B lymphocytes used in the human genomes study were
transformed in culture by infections of B95-8 strain of EBV,
it was surprising that the segment of sequence (~ 12 kb)
between 139 kb and 151 kb of WT-EBV genome that
B95-8 EBV genome does not possess could also be
found in the assembled NA12878 EBV consensus genome
sequence. Further analysis however revealed this spe-
cific ~ 12 kb segment of gene sequences (marked with
different colour on NA12878 EBV consensus genome in
Figure 2) was being covered less than 1/20 folds com-
pared with the average 464.9-fold coverage of the rest of
EBV genome. It appeared a small portion of human per-
ipheral blood B cells transformed by B95-8 strain of EBV
in 1000 human genomes project might already be infected
by EBVs carrying the gene segment that was not present
in B95-8 EBV. But the sequencing data clearly demon-
strated the large majority of EBV genome sequences
deposited in the project appeared to be closely related
to the B95-B strain lacking this specific segment of genes.
K4413-Mi EBV and K4123-Mi EBV are more closely related
to B95-8, WT-EBV, Mutu and NA12878 EBV
Pair-wise alignment of the newly assembled K4413-Mi
EBV, K4123-Mi EBV, NA12878 EBV and 7 other EBV
strains previously reported to GenBank with the WT-EBV
genomic sequence was performed. Figure 2 shows
the comparison result displayed by using the Mvista
program (http://genome.lbl.gov/vista/mvista/submit.shtml).Figure 2 Pair-wise alignment of genomic sequences for the newly ass
EBV strains previously reported to GenBank with the WT-EBV genom
identity with WT-EBV, except repeat regions (brown) and polymorphic gen
in AG876 (type 2). The region marked with yellow colour in the NA12878 E
NA12878 EBV genome in genome assembly. The figure was generated by m
of 50% and maximum identity of 100%.Overall sequence similarities for the WT-EBV genome with
the 10 other EBV genomes are high: K4413-Mi EBV (99%),
K4123-Mi EBV (99%), NA12878 EBV (100%), B95-8
(95%), Akata (98%), Mutu (100%), GD1 (97%), GD2 (96%),
HKNPC (96%), AG876 (96%). The region (13 kb - 42 kb)
with highly repetitive sequence in the EBV genome where
majority of gaps and ambiguity reads occurred was
not included for the genomic comparison (Figure 2).
Figure 2 shows that sequences in OriP (origin of DNA
replication), IR 3, 4 (internal repetitive family), and TR
(terminal repetitive family) regions among the EBV genomes
have lower similarity. There were also many sequence varia-
tions in polymorphic genes, such as EBNA-3A, 3B, and 3C
among these EBV genomes (Figure 2).
More importantly, comparison of sequences in the
region spanning EBNA3A, 3B and 3C for K4413-Mi
EBV and K4123-Mi EBV against WT-EBV genome re-
vealed much higher similarity with those of the B95-8
and Mutu genomes, but very different from the sequence
in this region of the AG876 genome.
Phylogenetic comparison for the genomic sequences
of K4413-Mi and K4123-Mi EBV with other EBVs asso-
ciated with various human diseases and from different
geographic areas
Multiple sequence alignment of K4413-Mi EBV, K4123-
Mi EBV, and the other 7 EBV genome sequences was per-
formed using the Kalign program in EBI (http://www.ebi.
ac.uk/Tools/msa/kalign/) and the Neighbour-joining trees
were constructed using MEGA 5 software (http://www.
megasoftware.net/) (Figure 3A). Phylogenetic analysis re-
vealed that K4413-Mi EBV and K4123-Mi EBV wereembled K4413-Mi EBV, K4123-Mi EBV, NA12878 EBV, and other 7
e. The 10 EBV genomes examined generally have high sequence
es (purple). EBNA3A, -3B, and -3C genes show lower sequence identity
BV genome has a significantly lower coverage than the rest of
VISTA software, using 100-bp moving window with minimum identity
Figure 3 Phylogenetic analysis of the 11 EBV genomes based on variations in the alignment of DNA and protein sequences of the 11 EBV
strains. Phylogenetic trees based on (A) DNA sequence alignment of the 11 EBV genomes. (B) Protein sequence alignment of LMP-1. (C) Protein
sequence alignment of EBNA-1. GD2 EBNA-1 is not included because the original GD2 EBNA-1 protein sequence is not available. Alignment was
done with the Kalign (for DNA) and Clustal Omega (for protein) program in EBI; Phylogenetic analysis was performed using MEGA software (version 5),
by Neighbour-joining (NJ) algorithm. The divergence scale (showing numbers of substitutions per site) is indicated at the foot of each tree.
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EBV. They were more different from GD1, GD2, and
HKNPC1, EBVs associated with NPC found in China
and Hong Kong as well as Akata, EBV from a case of
Burkitt’s lymphoma found in Japan. They were most
different from AG876, the type 2 EBV found in a case
of the Western African Burkitt’s lymphoma. Interest-
ingly, Mutu EBV from a case of Burkitt’s lymphoma in
Kenya is found to be more closely related to K4413-Mi
EBV, K4123-Mi EBV and B95-8 and WT-EBV (Figure 3A).
Phylogenetic trees generated from the alignment of trans-
lated amino acid sequences of LMP1 and EBNA-1 also
showed that K4413-Mi EBV and K4123-Mi EBV are
more distant from the NPC associated EBVs and Akata
strain of EBV from Burkitt’s lymphoma in East Asia
(Figures 3B, C).
Identification of variations from 2 immortalized human B
cell lines
We used the CLC Genomics Workbench to identify
variations, including single-nucleotide variants (SNVs),indels (insertion and deletions) in K4413-Mi and K4123-
Mi EBVs. In comparison with the WT-EBV reference
genome, a total of 444 variants with genome-wide dis-
tribution were found in the K4413-Mi EBV genomes
(Figure 4B). Among them, 418 variants were homogenous
SNVs; 10 variants were heterogeneous SNVs. In addition,
there were 9 insertions and 7 deletions. There were
424 variants located in the coding regions and 138 var-
iants were non-synonymous substitutions (Table 1 and
Additional file 1: Table S1). In comparison with the
WT-EBV reference genome, a total of 333 variants with
similar genome-wide distribution were found in the
K4123-Mi EBV genome (Figure 4A). Among them, 324
variants were homogenous SNVs; 1 variant was hetero-
geneous SNV. In addition, there were 2 insertions and 6
deletions. Among these variants, 329 variants were
located in the coding region and 110 variants were non-
synonymous substitutions (Table 1 and Additional file 2:
Table S2).
It is important to note that K4413-Mi and K4123-Mi
shared 97 common variants (Figure 4C). The common
Figure 4 Variants detected in EBV genomes of the 2 immortalized human B cell lines– in comparison with WT-EBV. The red bar indicates
the number of variants in the 1 kb region. (A) 333 variants with genome-wide distribution were found in the K4123-Mi EBV genomes. (B) 444 variants
with genome-wide distribution were found in the K4413-Mi EBV genomes. (C) 97 common variants were found in both K4413-Mi EBV and K4123-Mi
EBV genomes. (D) The CDS annotations for WT-EBV. The figure was generated by CLC Genomics Workbench.
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gions, e.g., from 6 kb to 10 kb, which is the region that
encodes EBER-1, 2 (EBV-encoded RNA) and contains
the OriP (the latent cycle origin of DNA replication),
and from 79 kb to 83 kb, the region that encodes
EBNA3 etc (Figure 4).
Discussion
We are evaluating the capability of detecting/characterizing
infectious viruses in human host cells through HTS gen-
omic sequencing using the Illumina Miseq platform and
different computational tools. In this study, we exam-
ined 2 human B lymphocyte cell lines that underwent
spontaneous immortalization promoted by mycoplasma
infection of the cell culture using the Illumina MiSeq
platform. We used the HTS data analytic program, CLC
Genomics Workbench, to classify the massive short se-
quence reads (49.5 and 45.3 million reads, ~175 bp/each)
generated from genomic sequencing of the 2 cell lines byTable 1 Summary of variations identified in EBVs of
the K4413-Mi and K4123-Mi cell lines–in comparison
with WT-EBV
K4413-Mi EBV K4123-Mi EBV
No. of variations 444 333
No. of SNVs (single-nucleotide variants) 428 325
No. of homozygous SNVs 418 324
No. of heterozygous SNVs 10 1
No. of indels (insertion or deletion) 16 8
No. of coding regions change 424 329
No. of non-synonymous substitutions 138 110mapping these sequences with human, bacterial, fungal,
and viral genomic databases from NCBI database respect-
ively (Figure 1A-D). The majority of reads obtained (97.2%
or 8.1 Gb for K4413-Mi cell line and 98.6% or 8.8 Gb for
K4123-Mi cell line), that was classified as human se-
quences, had approximately 1.22-fold and 1.34-fold cover-
age of a diploid human genome (6.6 Gb).
Consensus EBV genomes were constructed according
to the mapping result of the raw read with WT-EBV by
using the CLC Genomics Workbench. The K4413-Mi
EBV consensus genome was assembled by using 37,757
EBV-related reads (0.075% of total sequencing raw reads),
had 171,843 bp in length with ~ 35.22-fold coverage of
EBV genome. Thus, it is estimated that there are ~29
copies (35.22 vs 1.22 coverage) of EBV genome in a sin-
gle cell of the K4413-Mi lymphocyte cell line. Similarly,
the K4123-Mi EBV genome was assembled by using
28,178 EBV-related reads, and was 171,793 bp in length
with ~ 31.06-fold coverage of the EBV genome. It is esti-
mated that there are ~23 copies (31.06 vs 1.34 coverage)
of the EBV genome in a single cell of the K4123-Mi
lymphocyte cell line. The genome copy numbers of EBV
found in these resting human B lymphocytes that under-
went spontaneous immortalization are apparently higher
than those previously reported in the undifferentiated
NPC tumours. In GD2, there were ~ 6 copies of EBV
genome found in a single NPC tumour cell [14]. In com-
parison, the NA12878 EBV genome constructed from
NCBI database revealed an average of 102 copies of EBV
genome in each immortalized human lymphocyte in-
duced by infection of B95-8 EBV in culture. It appears
that there are many more copies of EBV genomes that
are present in each transformed human B lymphocyte
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eously transformed EBV-positive B-cell promoted by
infections of mycoplasma. The copy number of EBV
genomes found in an NPC tumour cell is evidently the
lowest.
Analysis of our results show that some sequences,
albeit very few, obtained in the genomic sequencing
of K4413-Mi and K4123-Mi human lymphocyte cell
lines mapped to bacteria, fungi, and non-EBV viruses
(Figure 1A-D). None-biased parallel HTS is capable of
picking up trace amounts of DNA molecules present in
culture media and serum. Most of the bacteria-related
sequences were mapped to Enterobacteria. When matched
with the NCBI viral database using the CLC Genomics
Workbench, 281 reads in K4413-Mi cell line were found
to be Enterobacteria phage phiX174. It is possible that
the bacteria in the medium also carried the Enterobac-
teria phage phiX174. Consistent with the original study
finding [17], no mycoplasma sequence was identified
in these cell lines. There are 593 reads in K4413-Mi
cell line and 548 reads in K4123-Mi were classified to
be other Herpesvirus-related sequence, not the EBV virus
(Figure 1B, D). We conducted the individual BlastN for
these 1141 reads. Most of these reads also matched with
EBV virus with low homology, and some reads matched
with Human sequence. In this context, 2.69% and 1.28%
of reads showed “no hits” in mapping against the 4 gen-
omic databases (human, bacteria, fungi, and virus) for the
K4413-Mi and K4123-Mi cell lines, respectively. When
these sequences were mapped using BlastN against NCBI
non-redundant databases, most of these sequences were
found to be human sequences. The CLC Genomics Work-
bench is a very powerful tool for NGS data analysis. It
allows us to quickly identify the read composition from
the massive amount of data. We also can effectively
detect and assemble the target viral EBV genome with
the CLC Genomics Workbench. Of course, all software
programs have its advantages and drawbacks. For bio-
informatics tools, parameter settings and databases used
will affect the outcome of the analysis. Different bio-
informatics tools are likely to produce different results.
We also tried the DNASTAR, SOAP package, BWA and
other bioinformatics tools for our analysis. The results
are slightly different from using the CLC Genomics
Workbench (data not shown). In this study, we only
present our analysis with the CLC program.
Whole-genome sequencing of EBV in the infected
cells enabled the determination and thus comparison of
EBV variations at the genome level. The constructed
genomes of K4413-Mi EBV and K4123-Mi EBV are
highly similar to each other and to the 8 other reported
EBV genomes in the GenBank. However, there are ap-
parent degrees of variations among the genomes of these
EBVs studied. Phylogenetic comparison of these EBVgenomes revealed that K4413-Mi EBV and K4123-Mi
EBV are more closely related to B95-8, EBV isolated from a
patient with infectious mononucleosis. They are evidently
more distant from GD1, GD2, and HKNPC1, EBVs associ-
ated with NPC tumours. Specific comparison for the two
particular EBV genes (LMP1 and EBNA-1) that were
considered risk-loci in NPC [19] and commonly used
for classification also revealed that K4413-Mi EBV and
K4123-Mi EBV are closer to B95-8 and more different
from NPC-related EBVs (Figure 3B, C). Furthermore, both
K4413-Mi EBV and K4123-Mi EBV lacked the 30 bp dele-
tion at the carboxyl terminus and a specific amino acid
substitution (Asp) at codon 335 with reference to Gly in
B95-8 LMP1, a feature that was reportedly present in
over 90% of EBVs found in NPC biopsies [20]. More-
over, K4413-Mi EBV and K4123-Mi EBV were evidently
more distant from AG876, EBV isolated from African
Burkitt’s lymphoma (Figures 2, 3A). Specific comparison
of sequences in the EBNA3 region that had been used
for classification of different EBV subtypes [21], simi-
larly revealed K4413-Mi EBV and K4123-Mi EBV were
more closely related to B95-8, a subtype 1 EBV (Figure 2).
They were most distant from AG876, a subtype 2 EBV
from the Western African case of Burkitt’s lymphoma.
Inclusion of the 2 most recently reported sequences
of EBV genomes, Akata and Mutu, in our analysis of
genomic sequence variations reveals the significant geo-
graphical distribution factor in addition to the factors
of disease or tissue association. K4413-Mi EBV and
K4123-Mi EBV are clearly more closely related to B95-8
strain and WT-EBV and more different from GD1, GD2
and HKNPC1 EBVs associated with NPC in the East Asia
and Akata-EBV strain from a Japanese case of Burkitt’s
lymphoma. They are clearly most different from the EBV
of Western Africa case of Burkitt’s lymphoma. However,
it is interesting to find that Mutu, EBV strain from a
Kenya case of Burkitt’s lymphoma in the East Africa is
more closely related to K4413-Mi EBV, K4123-Mi
EBV, B95-8 and WT-EBV found in the North America
(Figure 3A). More genome sequencing data of EBVs from
different geographic regions in the world in the future
could provide important information of the history or
the route of EBV dissemination as well as its evolution.
In this study, the geographical distribution factor in
sequence variations among these EBVs can similarly
be observed from the alignments of translated amino
acid sequences of LMP1 and EBNA-1 genes among these
EBVs of different origins (Figures 3B, C).
It may also be important to note that there were 10
heterogeneous SNPs found in the K4413-Mi EBV genome.
There was also 1 heterogeneous SNPs found in the
K4123-Mi EBV genome. The finding would suggest that
there could be more than two EBV variants or quasi
species within the K4413-Mi cell and K4123-Mi cell.
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We used the Illumina MiSeq sequencing platform, a NGS
technology and convenient computational tools, CLC
Genomics Workbench, to identify and extract EBV se-
quences from human B lymphocyte cell lines that under-
went spontaneous immortalization promoted by infection
of mycoplasma in culture. Genomes of EBVs identified
in the 2 immortalized human B lymphocytes were con-
structed and compared with all the other EBV genomes
available in GenBank. The study has demonstrated how
viral agents in infected human cells could be rapidly
identified, characterized and compared at the genomic
level through genomic sequencing and effective compu-
tational analysis. The EBVs found in these human B
lymphocytes are most closely related to B95-8 and WT-
EBV. They are less similar to EBVs found in NPC and
Burkitt’s lymphoma found in the East Asia. They are most
different from EBV associated with the Western African
Burkitt’s lymphoma based on whole genome sequences.
Methods
Sample preparation and short-read DNA sequencing
Two EBV-positive human B cell lines that underwent
spontaneous immortalization promoted by infections
of mycoplasma (namely K4413-Mi and K4123-Mi) were
cultured as described [17]. Both of the B-cell lines were
established from buffy coats of healthy blood donors
obtained from Department of Transfusion Medicine,
Warren Grant Magnuson Clinical Center, National In-
stitutes of Health (Bethesda, MD). Personal information
concerning these samples had been recorded in such a
manner that subjects could not be identified, directly or
through identifiers according to the HIPAA rules. Thus,
the ethnic and geographic origins of the donors are
not available. Genomic DNAs from these cell lines
were extracted using the DNAse Blood and Tissue Kit
(Qiagen). 50 ng DNA from each cell line was subjected to
DNA library construction using the Nextera DNA Kit
(Illumina) according to the manufacturer’s protocol. Briefly,
DNA library was prepared through procedures that in-
clude tagmentation and 5- cycle PCR amplification. The
DNA library has insert sizes ranging from 250 bp to
1000 bp. Two sequencing runs were conducted for each
sample studied. The 1st run sequencing used Illumina
Miseq reagent kit (300 cycles for the 2 × 150 bp pair-end
sequencing). The 2nd run of sequencing used Illumina
Miseq reagent kit V2 (500 cycles for the 2 × 250 bp pair-
end sequencing). The reads that passed Illumina quality
control filtering were used as raw data for further bio-
informatics analysis.
Taxonomic analysis of the short sequencing reads
The reference human database (hg19 human reference as-
sembly) was downloaded from the University of California,Santa Cruz (UCSC), (http://hgdownload.cse.ucsc.edu/down
loads.html#human); bacterial, fungal and viral databases
were downloaded from National Center for Biotechnol-
ogy Information (NCBI) (ftp://ftp.ncbi.nlm.nih.gov/genomes/
Bacteria/, 04/27/2013 version; ftp://ftp.ncbi.nlm.nih.gov/
genomes/Fungi/, 03/25/2013 version; ftp://ftp.ncbi.nlm.nih.
gov/genomes/Viruses/, 05/22/2013 version). These 4 data-
bases were uploaded to the CLC Genomics Workbench
to build the local database. All sequencing reads were
first aligned to the hg19 human database using the
CLC Genomics Workbench with the default parameters
(http://www.clcbio.com/, version 6.0.2). The matched
human reads were removed from the raw data set. Like-
wise, the remaining reads were aligned to the locally built
bacterial, fungal and viral databases sequentially using
the CLC Genomics Workbench.Assembly of the K4413-Mi EBV and K4123-Mi EBV genomes
The total raw reads of the K4413-Mi or K4123-Mi cell line
were aligned to the WT-EBV by using the CLC Genomics
Workbench with the default parameters. The matched reads
for each cell line were used for the EBV genome assembly.Identification of variations in the EBV genomic sequences
from the K4413-Mi and K4123-Mi cell lines
Using WT-EBV as a reference, the single nucleotide vari-
ations (SNVs), inserts and deletions (indels) and multiple
nucleotide variations (MNVs) were identified from the
K4413-Mi and K4123-Mi cell lines. MiSeq reads by using
the CLC Genomics Workbench with the default parameters.Comparative and phylogenetic analysis
A global comparison and visualization of WT-EBV against
K4413-Mi EBV, K4123-Mi EBV, NA12878 EBV, B95-8,
AG876, Akata, Mutu, GD1, GD2 and HKNPC1 was per-
formed using the mVISTA program (http://genome.lbl.gov/
vista/mvista/submit.shtml) with 100-bp moving window.
The global sequence alignments of the 11 EBV genomes
and individual gene sequence alignments were analyzed
using Kalign and Clustal Omega in EBI (http://www.ebi.
ac.uk/Tools/msa/kalign/; http://www.ebi.ac.uk/Tools/msa/
clustalo/) respectively. The alignments were used to gener-
ate phylogenetic trees using Molecular Evolutionary
Genetics Analysis (MEGA) software, version 5.0 [22] with
Neighbour-joining (NJ) algorithm.Nucleic sequence accession numbers
The full-length sequences of K4413-Mi EBV and K4123-Mi
EBV were submitted to the GenBank database with the
accession number KC440852 and KC440851.
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